WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CYTK

Based on 10 analysts offering 12 month price targets for Cytokinetics Inc.
Min Forecast
$77.00+29.35%
Avg Forecast
$95.00+59.58%
Max Forecast
$108.00+81.42%

Should I buy or sell CYTK stock?

Based on 10 analysts offering ratings for Cytokinetics Inc.
Buy
Strong Buy
3 analysts 30%
Buy
5 analysts 50%
Hold
2 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CYTK stock forecasts and price targets.

CYTK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-04-08
JP Morgan
Top 16%
85
Strong BuyMaintains$77.00+29.35%2024-03-07
Mizuho
Bottom 20%
20
Strong BuyMaintains$99.00+66.30%2024-03-06
UBS
Top 33%
68
HoldDowngrades$92.00+54.54%2024-01-24
Morgan Stanley
Top 15%
86
HoldDowngrades$90.00+51.18%2024-01-05
Raymond James
Bottom 24%
24
BuyMaintains$92.00+54.54%2023-12-28

1 of 1

Forecast return on equity

Is CYTK forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is CYTK forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CYTK revenue forecast

What is CYTK's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$13.7M+264.34%
Avg 2 year Forecast
$65.8M+1,653.07%
Avg 3 year Forecast
$309.3M+8,144.38%
CYTK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CYTK revenue growth forecast

How is CYTK forecast to perform vs Biotechnology companies and vs the US market?
Company
318.07%
Industry
37.22%
Market
9.95%
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CYTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CYTK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CYTK$59.53$95.00+59.58%Buy
EXEL$20.91$26.78+28.06%Buy
RVMD$39.41$43.11+9.39%Strong Buy
BPMC$104.96$115.77+10.30%Buy
HALO$44.71$54.00+20.78%Buy
View Top Biotech Stocks

Cytokinetics Stock Forecast FAQ

Is Cytokinetics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: CYTK) stock is to Buy CYTK stock.

Out of 10 analysts, 3 (30%) are recommending CYTK as a Strong Buy, 5 (50%) are recommending CYTK as a Buy, 2 (20%) are recommending CYTK as a Hold, 0 (0%) are recommending CYTK as a Sell, and 0 (0%) are recommending CYTK as a Strong Sell.

If you're new to stock investing, here's how to buy Cytokinetics stock.

What is CYTK's revenue growth forecast for 2024-2026?

(NASDAQ: CYTK) Cytokinetics's forecast annual revenue growth rate of 318.07% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Cytokinetics's revenue in 2024 is $3,752,000.On average, 9 Wall Street analysts forecast CYTK's revenue for 2024 to be $1,433,353,059, with the lowest CYTK revenue forecast at $88,077,291, and the highest CYTK revenue forecast at $5,662,111,572. On average, 9 Wall Street analysts forecast CYTK's revenue for 2025 to be $6,896,766,456, with the lowest CYTK revenue forecast at $423,609,829, and the highest CYTK revenue forecast at $23,686,500,076.

In 2026, CYTK is forecast to generate $32,434,357,601 in revenue, with the lowest revenue forecast at $23,487,277,632 and the highest revenue forecast at $57,764,023,426.

What is CYTK's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CYTK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CYTK's Price Target?

According to 10 Wall Street analysts that have issued a 1 year CYTK price target, the average CYTK price target is $95.00, with the highest CYTK stock price forecast at $108.00 and the lowest CYTK stock price forecast at $77.00.

On average, Wall Street analysts predict that Cytokinetics's share price could reach $95.00 by May 14, 2025. The average Cytokinetics stock price prediction forecasts a potential upside of 59.58% from the current CYTK share price of $59.53.

What is CYTK's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CYTK) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.